This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Herold, B. C.
Right arrow Articles by Shulman, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Herold, B. C.
Right arrow Articles by Shulman, N.

 Previous Article  |  Next Article 

J. Virol., Jun 1996, 3461-3469, Vol 70, No. 6
Copyright © 1996, American Society for Microbiology

Differences in the susceptibility of herpes simplex virus types 1 and 2 to modified heparin compounds suggest serotype differences in viral entry

BC Herold, SI Gerber, BJ Belval, AM Siston and N Shulman
Section of Pediatric Infectious Diseases and Committee on Virology, University of Chicago, Illinois 60637-1470, USA.

Although heparan sulfate (HS) serves as an initial receptor for the binding of both herpes simplex virus type 1 (HSV-1) and HSV-2 to cell surfaces, the two serotypes differ in epidemiology, cell tropism, and ability to compete for viral receptors in vitro. These observations are not necessarily contradictory and can be explained if the two serotypes recognize different structural features of HS. To compare the specific features of HS important for the binding and infection of HSV-1 and HSV- 2, we took advantage of structural similarities between heparin and cell surface HS and compared the abilities of chemically modified heparin compounds to inhibit plaque formation. We found that the antiviral activity of heparin for both serotypes was independent of anticoagulant activity. Moreover, specific negatively charged regions of the polysaccharide, including N sulfations and the carboxyl groups, are key structural features for interactions of both HSV-1 and HSV-2 with cell surfaces since N desulfation or carboxyl reduction abolished heparin's antiviral activity. In contrast, 6-O sulfations and 2-,3-O sulfations are important determinants primarily for HSV- 1 infection. The O-desulfated heparins had little or no inhibitory effect on HSV-1 infection but inhibited HSV-2 infection. Using a series of intertypic recombinant mutant viruses, we found that susceptibility to O- desulfated heparins can be transferred to HSV-1 by the gene for glycoprotein C of HSV-2 (gC-2). This supports the notion that the envelope glycoproteins of HSV-1 and HSV-2 interact with different affinities for different structural features of heparin. To determine if the modified heparin compounds inhibited plaque formation by competing with cell surface HS for viral attachment, binding studies were also performed. As anticipated, most compounds inhibited binding and plaque formation in parallel. However, several compounds inhibited the binding of HSV-1 to cells during the initial attachment period at 4 degrees C; this inhibitory effect was reversed when the cells and inoculum were shifted to 37 degrees C. This temperature-dependent differential response to modified heparin compounds was evident primarily when glycoprotein C of HSV-1 (gC-1) was present in the virion envelope. Minimal temperature-dependent differences were seen for HSV-1 with gC-1 deleted and for HSV-2. These results suggest differences in the interactions of HSV-1 and HSV-2 with cell surface HS that may influence cell tropism.


This article has been cited by other articles:

  • Kalia, M., Chandra, V., Rahman, S. A., Sehgal, D., Jameel, S. (2009). Heparan Sulfate Proteoglycans Are Required for Cellular Binding of the Hepatitis E Virus ORF2 Capsid Protein and for Viral Infection. J. Virol. 83: 12714-12724 [Abstract] [Full Text]  
  • Bultmann, H., Teuton, J., Brandt, C. R. (2007). Addition of a C-Terminal Cysteine Improves the Anti-Herpes Simplex Virus Activity of a Peptide Containing the Human Immunodeficiency Virus Type 1 TAT Protein Transduction Domain. Antimicrob. Agents Chemother. 51: 1596-1607 [Abstract] [Full Text]  
  • Schmidt, M., Chiorini, J. A. (2006). Gangliosides are essential for bovine adeno-associated virus entry.. J. Virol. 80: 5516-5522 [Abstract] [Full Text]  
  • Reddi, H. V., Kumar, A. S. M., Kung, A. Y., Kallio, P. D., Schlitt, B. P., Lipton, H. L. (2004). Heparan Sulfate-Independent Infection Attenuates High-Neurovirulence GDVII Virus-Induced Encephalitis. J. Virol. 78: 8909-8916 [Abstract] [Full Text]  
  • Basu, A., Beyene, A., Meyer, K., Ray, R. (2004). The Hypervariable Region 1 of the E2 Glycoprotein of Hepatitis C Virus Binds to Glycosaminoglycans, but This Binding Does Not Lead to Infection in a Pseudotype System. J. Virol. 78: 4478-4486 [Abstract] [Full Text]  
  • Zautner, A. E., Korner, U., Henke, A., Badorff, C., Schmidtke, M. (2003). Heparan Sulfates and Coxsackievirus-Adenovirus Receptor: Each One Mediates Coxsackievirus B3 PD Infection. J. Virol. 77: 10071-10077 [Abstract] [Full Text]  
  • Zago, A., Spear, P. G. (2003). Differences in the N Termini of Herpes Simplex Virus Type 1 and 2 gDs That Influence Functional Interactions with the Human Entry Receptor Nectin-2 and an Entry Receptor Expressed in Chinese Hamster Ovary Cells. J. Virol. 77: 9695-9699 [Abstract] [Full Text]  
  • Cheshenko, N., Herold, B. C. (2002). Glycoprotein B plays a predominant role in mediating herpes simplex virus type 2 attachment and is required for entry and cell-to-cell spread. J. Gen. Virol. 83: 2247-2255 [Abstract] [Full Text]  
  • Liu, J., Shriver, Z., Pope, R. M., Thorp, S. C., Duncan, M. B., Copeland, R. J., Raska, C. S., Yoshida, K., Eisenberg, R. J., Cohen, G., Linhardt, R. J., Sasisekharan, R. (2002). Characterization of a Heparan Sulfate Octasaccharide That Binds to Herpes Simplex Virus Type 1 Glycoprotein D. J. Biol. Chem. 277: 33456-33467 [Abstract] [Full Text]  
  • Anderson, R. A., Feathergill, K. A., Diao, X.-H., Cooper, M. D., Kirkpatrick, R., Herold, B. C., Doncel, G. F., Chany, C. J., Waller, D. P., Rencher, W. F., Zaneveld, L. J.D. (2002). Preclinical Evaluation of Sodium Cellulose Sulfate (Ushercell) as a Contraceptive Antimicrobial Agent. J Androl 23: 426-438 [Abstract] [Full Text]  
  • Martinez-Barragan, J. d. J., del Angel, R. M. (2001). Identification of a Putative Coreceptor on Vero Cells That Participates in Dengue 4 Virus Infection. J. Virol. 75: 7818-7827 [Abstract] [Full Text]  
  • Kaludov, N., Brown, K. E., Walters, R. W., Zabner, J., Chiorini, J. A. (2001). Adeno-Associated Virus Serotype 4 (AAV4) and AAV5 Both Require Sialic Acid Binding for Hemagglutination and Efficient Transduction but Differ in Sialic Acid Linkage Specificity. J. Virol. 75: 6884-6893 [Abstract] [Full Text]  
  • Bultmann, H., Busse, J. S., Brandt, C. R. (2001). Modified FGF4 Signal Peptide Inhibits Entry of Herpes Simplex Virus Type 1. J. Virol. 75: 2634-2645 [Abstract] [Full Text]  
  • Trybala, E., Liljeqvist, J.-A., Svennerholm, B., Bergström, T. (2000). Herpes Simplex Virus Types 1 and 2 Differ in Their Interaction with Heparan Sulfate. J. Virol. 74: 9106-9114 [Abstract] [Full Text]  
  • Skrincosky, D., Hocknell, P., Whetter, L., Secchiero, P., Chandran, B., Dewhurst, S. (2000). Identification and Analysis of a Novel Heparin-Binding Glycoprotein Encoded by Human Herpesvirus 7. J. Virol. 74: 4530-4540 [Abstract] [Full Text]  
  • Laquerre, S., Argnani, R., Anderson, D. B., Zucchini, S., Manservigi, R., Glorioso, J. C. (1998). Heparan Sulfate Proteoglycan Binding by Herpes Simplex Virus Type 1 Glycoproteins B and C, Which Differ in Their Contributions to Virus Attachment, Penetration, and Cell-to-Cell Spread. J. Virol. 72: 6119-6130 [Abstract] [Full Text]  
  • Immergluck, L., Domowicz, M., Schwartz, N., Herold, B. (1998). Viral and cellular requirements for entry of herpes simplex virus type 1 into primary neuronal cells. J. Gen. Virol. 79: 549-559 [Abstract]  
  • Trybala, E., Bergstrom, T., Spillmann, D., Svennerholm, B., Flynn, S. J., Ryan, P. (1998). Interaction between Pseudorabies Virus and Heparin/Heparan Sulfate. PSEUDORABIES VIRUS MUTANTS DIFFER IN THEIR INTERACTION WITH HEPARIN/HEPARAN SULFATE WHEN ALTERED FOR SPECIFIC GLYCOPROTEIN C HEPARIN-BINDING DOMAIN. J. Biol. Chem. 273: 5047-5052 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»